These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2624216)

  • 1. Exercise induced alteration of erythrocyte glycolysis associated with myogenic hyperuricemia.
    Shimizu T; Kono N; Kiyokawa H; Yamada Y; Hara N; Mineo I; Kawachi M; Nakajima H; Wang YL; Kuwajima M
    Adv Exp Med Biol; 1989; 253A():375-9. PubMed ID: 2624216
    [No Abstract]   [Full Text] [Related]  

  • 2. Myogenic hyperuricemia: a comparative study between type V and type VII glycogenosis.
    Hara N; Mineo I; Kono N; Kiyokawa H; Kawachi M; Yamada Y; Nakajima H; Shimizu T; Kuwajima M; Wang YL
    Adv Exp Med Biol; 1989; 253A():381-6. PubMed ID: 2624217
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myogenic hyperuricemia].
    Yamasaki T; Hamaguchi T; Nakajima H; Matsuzawa Y
    Nihon Rinsho; 1996 Dec; 54(12):3343-8. PubMed ID: 8976117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    Mineo I; Kono N; Hara N; Shimizu T; Yamada Y; Kawachi M; Kiyokawa H; Wang YL; Tarui S
    N Engl J Med; 1987 Jul; 317(2):75-80. PubMed ID: 3473284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
    Mineo I; Kono N; Shimizu T; Hara N; Yamada Y; Sumi S; Nonaka K; Tarui S
    J Clin Invest; 1985 Aug; 76(2):556-60. PubMed ID: 3861621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricemia in type V glycogenosis.
    Hardiman O; Farrell M; McElvaney G; Tipton K; Staunton H
    Neurology; 1987 Apr; 37(4):728-9. PubMed ID: 3470631
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myogenic hyperuricemia].
    Mineo I; Kawachi M; Kono N; Tarui S
    Nihon Rinsho; 1991 May; 49(5):1043-9. PubMed ID: 2067092
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycogenosis type V (McArdle's disease) with hyperuricemia. A case report and clinical investigation.
    Jinnai K; Kono N; Yamamoto Y; Kanda F; Ohno S; Tsutsumi M; Yamada Y; Kawachi M; Tarui S; Fujita T
    Eur Neurol; 1993; 33(3):204-7. PubMed ID: 8467838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular aspect of myogenic hyperuricemia: cloning of human muscle phosphofructokinase cDNA.
    Nakajima H; Noguchi T; Mineo I; Yamasaki T; Kono N; Tanaka T; Tarui S
    Adv Exp Med Biol; 1989; 253A():485-91. PubMed ID: 2533850
    [No Abstract]   [Full Text] [Related]  

  • 10. A genetic defect in muscle phosphofructokinase deficiency, a typical clinical entity presenting myogenic hyperuricemia.
    Nakajima H; Kono N; Yamasaki T; Hotta K; Kawachi M; Hamaguchi T; Nishimura T; Mineo I; Kuwajima M; Noguchi T
    Adv Exp Med Biol; 1991; 309B():141-4. PubMed ID: 1838230
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperuricemia in childhood.
    Howell RR
    Fed Proc; 1968; 27(4):1078-82. PubMed ID: 4232132
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperlactacidemia, probable cause of hyperuricemia, in hepatic glycogenosis].
    JEANDET J; LESTRADET H
    Rev Fr Etud Clin Biol; 1961 Jan; 6():71-2. PubMed ID: 13789700
    [No Abstract]   [Full Text] [Related]  

  • 13. Disorders of glycogen metabolism of muscle.
    DiMauro S; Bresolin N; Hays AP
    CRC Crit Rev Clin Neurobiol; 1984; 1(2):83-116. PubMed ID: 6242726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of exercise on serum uric acid].
    Hashizume N; Matsumoto T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():138-42. PubMed ID: 12629707
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperuricemia in glycogen-storage disease type 1.
    Fine RN; Strauss J; Donnell GN
    Am J Dis Child; 1966 Dec; 112(6):572-6. PubMed ID: 5224881
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysosomal glycogen storage disease with normal acid maltase.
    Danon MJ; Oh SJ; DiMauro S; Manaligod JR; Eastwood A; Naidu S; Schliselfeld LH
    Neurology; 1981 Jan; 31(1):51-7. PubMed ID: 6450334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glycogenosis (molecular mechanism of muscle glycogenosis)].
    Tarui S; Mineo I; Nakajima H; Kono N
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):637-42. PubMed ID: 3270875
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperuricemia: a marker for cell energy crisis.
    Fox IH; Palella TD; Kelley WN
    N Engl J Med; 1987 Jul; 317(2):111-2. PubMed ID: 3473283
    [No Abstract]   [Full Text] [Related]  

  • 19. Portal diversion for the treatment of glycogen storage disease in humans.
    Starzl TE; Putnam CW; Porter KA; Halgrimson CG; Corman J; Brown BI; Gotlin RW; Rodgerson DO; Greene HL
    Ann Surg; 1973 Oct; 178(4):525-39. PubMed ID: 4517839
    [No Abstract]   [Full Text] [Related]  

  • 20. Uric acid transport characteristics in human erythrocytes.
    Lucas-Heron B; Fontenaille C
    Adv Exp Med Biol; 1977; 76B():151-8. PubMed ID: 16456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.